Bo Ahrén

101 – 110 of 398

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/af6f8d38-a95b-47b6-9ec5-5f69aa8d0e59?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
10
11
12
13
…
40
next »

2014
Mark The mind and the belly: a glance at how the nervous system directs metabolism
Accili, D. ; Ahrén, Bo ^LU ; Boitard, C. ; Seino, S. ; Thorens, B. and Cerasi, E. (2014) In Diabetes, Obesity and Metabolism 16. p.1-3
- Contribution to journal › Debate/Note/Editorial
Mark Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes.
Ahrén, Bo ^LU (2014) In World Journal of Diabetes 5(1). p.40-51
- Contribution to journal › Scientific review
Mark Glucagon clearance is regulated by nutritional state : Evidence from experimental studies in mice
Zhou, Alyssa ; Pacini, Giovanni ; Ahrén, Bo ^LU and D'Argenio, David Z. (2014) In Diabetologia 57(4). p.801-808
- Contribution to journal › Article
Mark Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial
Jakubowicz, Daniela ; Froy, Oren ; Ahrén, Bo ^LU ; Boaz, Mona ; Landau, Zohar ; Bar-Dayan, Yosefa ; Ganz, Tali ; Barnea, Maayan and Wainstein, Julio (2014) In Diabetologia 57(9). p.1807-1811
- Contribution to journal › Article
Mark Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro.
Rosenstock, Julio ; Fonseca, Vivian A ; Gross, Jorge L ; Ratner, Robert E ; Ahrén, Bo ^LU ; Chow, Francis C C ; Yang, Fred ; Miller, Diane ; Johnson, Susan L and Stewart, Murray W , et al. (2014) In Diabetes Care 37(8). p.2317-2325
- Contribution to journal › Article
2013
Mark Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion.
Ahlkvist, Linda ^LU ; Brown, K and Ahrén, Bo ^LU (2013) In Endocrine Connections 2(2). p.69-78
- Contribution to journal › Article
Mark Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
Monami, M. ; Ahrén, Bo ^LU ; Dicembrini, I. and Mannucci, E. (2013) In Diabetes, Obesity and Metabolism 15(2). p.112-120
- Contribution to journal › Article
Mark Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function
Alba, M. ; Ahrén, Bo ^LU ; Inzucchi, S. E. ; Guan, Y. ; Mallick, M. ; Xu, L. ; O'Neill, E. A. ; Williams-Herman, D. E. ; Kaufman, K. D. and Goldstein, B. J. (2013) In Diabetes, Obesity and Metabolism 15(12). p.1101-1110
- Contribution to journal › Article
Mark Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
Johansson, Per ^LU ; Aberg, Daniel ; Johansson, Jan-Ove ; Mattsson, Niklas ; Hansson, Oskar ^LU ; Ahrén, Bo ^LU ; Isgaard, Jorgen ; Aberg, N. David ; Blennow, Kaj ^LU and Zetterberg, Henrik , et al. (2013) In Psychoneuroendocrinology 38(9). p.1729-1737
- Contribution to journal › Article
Mark Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives.
Ahrén, Bo ^LU (2013) In Diabetes & Metabolism 39(3). p.195-201
- Contribution to journal › Scientific review

« previous
1
…
10
11
12
13
…
40
next »